Mutual of America Capital Management LLC Reduces Stock Position in Orthofix Medical Inc. (NASDAQ:OFIX)

Mutual of America Capital Management LLC lessened its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 0.9% during the 2nd quarter, Holdings Channel reports. The firm owned 174,149 shares of the medical device company’s stock after selling 1,522 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Orthofix Medical were worth $2,309,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD grew its stake in Orthofix Medical by 3.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 32,957 shares of the medical device company’s stock valued at $479,000 after purchasing an additional 1,236 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Orthofix Medical by 25.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock valued at $125,000 after purchasing an additional 1,919 shares during the last quarter. nVerses Capital LLC acquired a new position in shares of Orthofix Medical in the 2nd quarter valued at about $27,000. State Board of Administration of Florida Retirement System lifted its holdings in shares of Orthofix Medical by 34.7% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 13,562 shares of the medical device company’s stock valued at $197,000 after buying an additional 3,490 shares during the period. Finally, Gabelli Funds LLC lifted its holdings in shares of Orthofix Medical by 3.3% in the 4th quarter. Gabelli Funds LLC now owns 139,500 shares of the medical device company’s stock valued at $1,880,000 after buying an additional 4,500 shares during the period. Hedge funds and other institutional investors own 89.76% of the company’s stock.

Orthofix Medical Stock Performance

Shares of OFIX stock opened at $15.61 on Wednesday. The stock has a market cap of $585.83 million, a PE ratio of -4.62 and a beta of 1.05. The business has a 50-day simple moving average of $16.42 and a 200-day simple moving average of $14.75. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. Orthofix Medical Inc. has a 52-week low of $9.57 and a 52-week high of $17.67.

Orthofix Medical (NASDAQ:OFIX) last issued its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.58). The company had revenue of $198.62 million during the quarter, compared to analyst estimates of $195.75 million. Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. On average, equities analysts expect that Orthofix Medical Inc. will post -2.13 EPS for the current year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.